Skip to main content

Table 1 Urinary ADAM 12 of cancer patient group vs. control group

From: Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation

 

Cancer group: pre-surgery

Cancer group: post-surgery

Control group

 

(n = 50)

(n = 49)

(n = 46)

Age

Mean: 60.9 ± 13.0

Mean: 60.9 ± 13.0

Mean: 60.1 ± 12.4

Median: 60

Median: 60

Median: 60

[ADAM 12] (ng/mL)

Mean: 3.36 ± 3.04

Mean: 16.3 ± 15.6

Mean: 3.52 ± 3.17

Median: 2.48

Median: 10.3

Median: 2.77

Total protein (μg/mL)

Mean: 60.7 ± 53.6

Mean: 59.7 ± 32.9

Mean: 78.6 ± 65.6

Median: 42.0

Median: 59.0

Median: 58.7

ADAM 12 as % of total protein

Mean: 0.008 ± 0.01

Mean: 0.03 ± 0.03

Mean: 0.006 ± 0.006

 

Median: 0.005

Median: 0.017

Median: 0.004

  1. Cancer group consists of DCIS (n = 15) and IBC (n = 35) diagnoses.